Comparasion of therapeutic effects of Chinese rapamycin-eluting stent and imported paclitaxel-eluting stent in treatment of acute myocardial infarction
10.3760/cma.j.issn.1008-6315.2010.08.017
- VernacularTitle:国产雷帕霉素支架和进口紫杉醇支架治疗急性心肌梗死的对比研究
- Author:
Youlin MAO
;
Yiqiang YUAN
;
Li YU
;
Ruimin WANG
;
Yun SUN
;
Shuang SONG
- Publication Type:Journal Article
- Keywords:
Coronary disease;
Acute myocardial infarction;
Stents;
Cardiac events
- From:Clinical Medicine of China
2010;26(8):828-830
- CountryChina
- Language:Chinese
-
Abstract:
Objective To compare the clinical outcomes of Chinese rapamycin-eluting stents (Firebird stents) and imported paclitaxel-eluting stents ( Taxus stents ) in the treatment of acute myocardial infarction. Methods Ninety-seven patients with ST segment elevated acute myocardial infarction were treated with Firebird stents (in 51 patients) and Taxus stents (in 46 patients). The death rate, re-acute myocardial infarction, target lesion revascularization (TLR) ,and major adverse cardiac event (MACE) within 9 months after percutaneous coronary intervention ( PCI) were observed between the two groups. Results The rate of successful stent-implantation, angina,death, re-acute myocardial infarction, TLR and MACE was 100% ,9. 8% ,0% ,2. 0% ,0% , 11. 8% in the Firebird stent group and 100% ,8. 7% ,0% ,2. 2% ,0% ,0% and 10.9% in the Taxus stents group within 9 months after PCI. There was no significant difference between the two groups. Conclusions There is no significant difference in the clinical effect between the Firebird stent group and Taxus stent group within 9 months after PCI. However, the effect-cost ratio is better in the Firebird stent than the Taxus stent.
